Back to Search
WILLIAM BISHOP, M.D.
M.D.
Emergency Medicine Physician
NPI: 1487819223IndividualAccepts Medicare
Specialties, Licenses & Credentials
Emergency Medicine PhysicianPrimary
Emergency Medicine
Code: 207P00000X
4301091999(MI)55918(WI)
Emergency Medical Services (Emergency Medicine) Physician
Emergency Medicine — Emergency Medical Services
Code: 207PE0004X
55918(WI)
CMS Specialties
PrimaryEMERGENCY MEDICINE
Education
UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE
Class of 2008
Research & Publications (20)
The use of a virtual integration environment for the real-time implementation of neural decode algorithms.
PMID 19162734·Annu Int Conf IEEE Eng Med Biol Soc·2008
7-preclinical
A real-time virtual integration environment for the design and development of neural prosthetic systems.
PMID 19162731·Annu Int Conf IEEE Eng Med Biol Soc·2008
8-other
Continuous and intermittent dosing of lonafarnib potentiates the therapeutic efficacy of docetaxel on preclinical human prostate cancer models.
PMID 19530253·Int J Cancer·2009
7-preclinical
Outcomes with first-line platinum-based combination chemotherapy for malignant pleural mesothelioma: a review of practice in British Columbia.
PMID 19004520·Lung Cancer·2009
8-other
Combining the farnesyltransferase inhibitor lonafarnib with paclitaxel results in enhanced growth inhibitory effects on human ovarian cancer models in vitro and in vivo.
PMID 18237771·Gynecol Oncol·2008
7-preclinical
Initial clinical experience with allopurinol-thiopurine combination therapy in pediatric inflammatory bowel disease.
PMID 18521913·Inflamm Bowel Dis·2008
8-other
Percutaneous liver biopsy practice patterns among pediatric gastroenterologists in North America.
PMID 17592369·J Pediatr Gastroenterol Nutr·2007
8-other
Azathioprine monotherapy for maintenance of remission in pediatric patients with autoimmune hepatitis.
PMID 16954959·J Pediatr Gastroenterol Nutr·2006
5-case
Lipid posttranslational modifications. Farnesyl transferase inhibitors.
PMID 16278491·J Lipid Res·2006
6-review
Enhanced FTase activity achieved via piperazine interaction with catalytic zinc.
PMID 16298128·Bioorg Med Chem Lett·2006
8-other
Evolution of thiopurine use in pediatric inflammatory bowel disease in an academic center.
PMID 16954954·J Pediatr Gastroenterol Nutr·2006
8-other
The farnesyl transferase inhibitor (FTI) SCH66336 (lonafarnib) inhibits Rheb farnesylation and mTOR signaling. Role in FTI enhancement of taxane and tamoxifen anti-tumor activity.
PMID 16006564·J Biol Chem·2005
7-preclinical
Inhibition of insulin-like growth factor-I receptor (IGF-IR) signaling and tumor cell growth by a fully human neutralizing anti-IGF-IR antibody.
PMID 16093437·Mol Cancer Ther·2005
7-preclinical
Ulcerative colitis complicated by ischemic colitis and Budd Chiari syndrome.
PMID 15625435·J Pediatr Gastroenterol Nutr·2005
5-case
Effect of Helicobacter pylori infection on gastric acid secretion and iron absorption: can we iron out the issue?
PMID 15625441·J Pediatr Gastroenterol Nutr·2005
8-other
Integrative genomics revealed RAI3 is a cell growth-promoting gene and a novel P53 transcriptional target.
PMID 15659406·J Biol Chem·2005
8-other
An unusual intestinal presentation of C-ANCA/PR-3 positive vasculitis in a child.
PMID 15735495·J Pediatr Gastroenterol Nutr·2005
5-case
Radiographic and endoscopic measurements of esophageal length in pediatric patients.
PMID 16190090·Ann Otol Rhinol Laryngol·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1836 SOUTH AVE
LA CROSSE, WI 54601 - Phone
- (608) 782-7300
Quick Facts
- NPI
- 1487819223
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 18
- Publications
- 20
Are you this provider?
Claim Your Profile